Effect of Concentrate Pomegranate Juice and Cardiovascular Factors in Patients with Type 2 Diabetes

Although current information shows that pomegranate in type 2 diabetic patients can improve control blood sugar and lipids profile there are controversial results about its relevance to improving blood sugar and lipids in diabetes. This survey investigated the influence of concentrate pomegranate juice (CPJ) on fasting blood sugar, lipid profile, total antioxidant capacity (TAC) and Blood pressure (BP). This is a quasi clinical trial which was conducted on 40 type 2 diabetic patients in Golestan hospital in Ahvaz in 2013. Fasting blood samples were taken at baseline and after 4 WK of intervention to measure FBS, lipid profile and TAC. While high density lipoprotein cholesterol (HDL-C) was significantly increased after intervention. Also, the results indicated that CPJ for 4 wk significantly increase plasma levels of TAC (p<0/001). Whereas no change was made in levels of FBS, TG, LDL-c, BP. It is concluded that CPJ have significant positive effects on HDL and TAC in patients with type 2 diabetes which may be attributed to its polyphenolic content. Further investigations are needed with stronger design, larger sample size.